On 18 May 2023, NCET took the decision to retire the MPX Living Guidelines for the foreseeable future, given the national and international health and research landscapes. A few weeks earlier, WHO director-general Tedros Adhanom Ghebreyesus announced that MPX was no longer a public health emergency of international concern and pointed to global progress in controlling the outbreaks in recent months. There are currently very few cases of MPX in Australia, there is scant evidence on MPX being published globally, and the major trials we do know of will not be reporting until much later in 2023. We look forward to exploring the findings from more significant studies when they are published in late 2023.
In the meantime, the MPX Guidelines remain freely accessible but as at May 2023, are not being regularly updated. You can find out more about our MPX work and decision to retire them in our news section.
As of 31 July 2023, the National Clinical Evidence Taskforce is no longer funded. The COVID-19 and MPX guidelines are still accessible online, but are not currently being updated.
For more information and the latest developments in Australian living evidence visit livingevidence.org.au
Evidence-based clinical Monkeypox (MPX) guidelines updated with the latest research
Your views help us to identify and prioritise questions to include in the living guideline.
Submit your questions here
Subscribe here to receive regular updates from the Taskforce